Lamarck Redux: Transgenerational genetic effects on phenotypes and disease

Lamarck Redux:跨代遗传对表型和疾病的影响

基本信息

  • 批准号:
    8517171
  • 负责人:
  • 金额:
    $ 86.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

Traditionally genetics has focused on direct associations between genotypes and phenotypes within individuals. This logical focus on principles of Mendelian genetics has led to a revolution in our understanding of fundamental biological processes and disease genetics. However, observations such as 'missing heritability' in genome-wide association studies suggest that our explanations for phenotypic variation and disease risk are incomplete in important ways. In addition, several recent reports of interacting genes in different generations and transgenerational genetic effects strongly suggest that alternative modes of inheritance exist. These reports involve a wide variety of embryonic and adult traits and can lead to dysfunctions and diseases such as embryonic lethality, cancer, obesity and anxiety. Attributing phenotypes to gene action in previous generations is a fundamental and profound observation that suggests that both epigenetic (non-DNA) and genetic (DNA) mechanisms guide inheritance. Our discoveries implicate RNA editing, miRNA biology, translation control as well as perhaps RNA granules in these transgenerational effects. Proposed work will identify the molecular basis for transgenerational effects and characterize the mechanisms for epigenetics across generations. My accomplishments in comparative genomics, the developmental biology of neural tube defects and testicular cancer, the physiological genetics of obesity and metabolic diseases, and the genetic architecture of complex traits demonstrate my ability to identify hard problems and make important contributions in an unusually wide variety of biomedical fields. The proposed work on transgenerational genetic effects represents a new and exciting area of research, partly because it involves questions and technologies that I am eager to learn, but more importantly because the results could revolutionize our understanding of the molecular mechanisms of inheritance as well as assessment of phenotypic variation and disease risk.
传统上,遗传学关注基因型和表型之间的直接关联, 个体这种对孟德尔遗传学原理的逻辑关注,导致了我们人类遗传学的一场革命。 了解基本的生物学过程和疾病遗传学。然而,这样的观察 作为全基因组关联研究中的“缺失遗传性”, 变异和疾病风险在重要方面是不完整的。此外,最近有几份报告称, 不同世代的相互作用基因和跨代遗传效应强烈表明, 存在替代的继承模式。这些报告涉及各种各样的胚胎和成年性状 并可能导致功能障碍和疾病,如胚胎死亡、癌症、肥胖和焦虑。 将表型归因于前几代的基因作用是一个基本而深刻的观察 这表明表观遗传(非DNA)和遗传(DNA)机制都指导遗传。我们 这些发现涉及RNA编辑,miRNA生物学,翻译控制以及可能的RNA颗粒。 这些跨代效应。拟议的工作将确定跨代的分子基础 影响和表征跨代表观遗传学的机制。我的成就 比较基因组学,神经管缺陷和睾丸癌的发育生物学, 肥胖和代谢疾病的生理遗传学,以及复杂性状的遗传结构 证明我的能力,以确定困难的问题,并作出重要贡献,在一个异常广泛的 各种生物医学领域。关于跨代遗传效应的拟议工作代表了一种新的 令人兴奋的研究领域,部分原因是它涉及的问题和技术,我渴望 学习,但更重要的是,因为结果可能会彻底改变我们对分子的理解, 遗传机制以及表型变异和疾病风险的评估。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH H. NADEAU其他文献

JOSEPH H. NADEAU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH H. NADEAU', 18)}}的其他基金

Master regulators of unexplained variation in disease risk
疾病风险无法解释的变异的主要调节因素
  • 批准号:
    10492766
  • 财政年份:
    2021
  • 资助金额:
    $ 86.43万
  • 项目类别:
Master regulators of unexplained variation in disease risk
疾病风险无法解释的变异的主要调节因素
  • 批准号:
    10670982
  • 财政年份:
    2021
  • 资助金额:
    $ 86.43万
  • 项目类别:
Master regulators of unexplained variation in disease risk
疾病风险无法解释的变异的主要调节因素
  • 批准号:
    10273583
  • 财政年份:
    2021
  • 资助金额:
    $ 86.43万
  • 项目类别:
Pilot Project Program
试点项目计划
  • 批准号:
    10675601
  • 财政年份:
    2017
  • 资助金额:
    $ 86.43万
  • 项目类别:
Pilot Project Program
试点项目计划
  • 批准号:
    10505156
  • 财政年份:
    2017
  • 资助金额:
    $ 86.43万
  • 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
  • 批准号:
    8722583
  • 财政年份:
    2010
  • 资助金额:
    $ 86.43万
  • 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
  • 批准号:
    8645834
  • 财政年份:
    2010
  • 资助金额:
    $ 86.43万
  • 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
  • 批准号:
    8316233
  • 财政年份:
    2010
  • 资助金额:
    $ 86.43万
  • 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
  • 批准号:
    8152152
  • 财政年份:
    2010
  • 资助金额:
    $ 86.43万
  • 项目类别:
Lamarck Redux: Transgenerational genetic effects on phenotypes and disease
Lamarck Redux:跨代遗传对表型和疾病的影响
  • 批准号:
    7979938
  • 财政年份:
    2010
  • 资助金额:
    $ 86.43万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Research Grant
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Launchpad
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Collaborative R&D
Application name Phase Space - VR hypnotherapy as early intervention for anxiety in students and young people
应用程序名称 Phase Space - VR 催眠疗法作为学生和年轻人焦虑的早期干预
  • 批准号:
    10055011
  • 财政年份:
    2023
  • 资助金额:
    $ 86.43万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了